Samuel Isaly, Orbimed Advisors Lower Position in NxStage Medical

Samuel Isaly‘s hedge fund, Orbimed Advisors, decreased its stake in NxStage Medical, Inc. (NASDAQ:NXTM) to around 2.89 million shares, from 3.14 million held earlier. Following the decline in holdings, Orbimed’s position amasses 4.73% of NxStage’s common stock, versus 5.25% reported in an earlier filing.

NxStage Medical, Inc. (NASDAQ:NXTM)

Disclosure: none

Recommended Reading:

Steven Cohen, SAC Capital Boost Position in Vitamin Shoppe

Baker Bros. Decreases Exposure at Viropharma

Earnest Partners Decreases Position in Astoria Financial Corp; Ups Stake in Meritage Homes Corp